The compounds of Formula I act as MGAT2 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.
Formula I的化合物作为MGAT2抑制剂,可用于预防、治疗或作为高脂血症、糖尿病和肥胖的治疗药物。
2,6-disubstituted derivatives of 3-nitropyrazines useful as adjuncts to
申请人:Merck & Co., Inc.
公开号:US04709035A1
公开(公告)日:1987-11-24
2,6-Disubstituted derivatives of 3-nitropyrazine are disclosed to have activity in increasing the sensitivity of tumor cells to radiation. Also disclosed are methods of preparing such compounds and pharmaceutical compositions including such compounds.
Synthesis and activity of novel nitropyrazines for use as hypoxic cell radiosensitizers
作者:George D. Hartman、Richard D. Hartman、John E. Schwering、Nigel R. Jones、Peter Wardman、Margaret E. Watts、Michael Woodcock
DOI:10.1021/jm00378a018
日期:1984.12
A series of eight novel nitropyrazines has been prepared by oxidation of sulfoximine intermediates. The partition coefficient, one-electron reduction potential, sensitizer enhancement ratio, and chronic and acute aerobic cytotoxicity have been measured for each. Two representatives of this series were tested in the Ames test and were not found to be mutagenic.
HARTMAN, G. D.;SCHWERING, J. E., J. HETEROCYCL. CHEM., 1983, 20, N 4, 947-950
作者:HARTMAN, G. D.、SCHWERING, J. E.
DOI:——
日期:——
HARTMAN, G. D.;HARTMAN, R. D.;SCHWERING, J. E.;SAARI, W. S.;ENGELHARDT, E+, J. MED. CHEM., 1984, 27, N 12, 1634-1639
作者:HARTMAN, G. D.、HARTMAN, R. D.、SCHWERING, J. E.、SAARI, W. S.、ENGELHARDT, E+